OC
GMED icon

Oppenheimer & Co’s Globus Medical GMED Stock Holding History

Oppenheimer & Co’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-7,903
Closed -$203K – 1395
2015
Q2 		$203K Buy
+7,903
New +$200K 0.01% 1294

Other funds holding GMED

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.51B AUM 37.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return
KI
Kalmar Investments Greenville, Delaware $443M AUM 23.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Oppenheimer & Co's GMED Position: Q3 2015 in Review

Oppenheimer & Co sold out of Globus Medical (GMED) in Q3 2015, closing a stake of 7,903 shares — an estimated $203K sold.

Oppenheimer & Co first reported a position in GMED in Q2 2015 and held it in 1 quarter. The position peaked at $203K in Q2 2015. 182 funds tracked by Wall St. Rank hold GMED as of Q3 2015.

  • Oppenheimer & Co reported no remaining Globus Medical position as of Q3 2015 after selling out during the quarter.
  • Oppenheimer & Co sold 7,903 Globus Medical shares in Q3 2015, an estimated $203K.
  • Oppenheimer & Co first reported a position in Globus Medical in Q2 2015 and held it in 1 quarter.
  • Oppenheimer & Co's Globus Medical position peaked at $203K in Q2 2015.
  • 182 funds tracked by Wall St. Rank held Globus Medical as of Q3 2015.

Based on Oppenheimer & Co's 13F filing for Q3 2015, filed 13 Nov 2015.